Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 95.39%-17.38K | 91.23%-42.26K | 64.20%-11.21K | -1,775.18%-896.99K | -117.52%-6.56K | -270.11%-377.03K | -2,831.35%-482.09K | -194.69%-31.32K | 84.65%-47.84K | 27.87%37.41K |
| Net income from continuing operations | 87.16%-46.5K | 18.67%-72.96K | -45.50%-40.68K | -43.31%-525.12K | 74.15%-45.37K | -432.40%-362.08K | 58.89%-89.7K | -129.33%-27.96K | -147.70%-366.42K | -228.62%-175.5K |
| Operating gains losses | ---- | -121.81%-27.63K | ---- | --126.67K | --0 | ---- | --126.67K | ---- | ---- | ---- |
| Depreciation and amortization | ---9.52K | --19.2K | --19.2K | --30.64K | --30.64K | --0 | --0 | --0 | --0 | ---- |
| Asset impairment expenditure | ---- | ---- | ---- | 4.00%27.85K | ---- | ---- | ---- | ---- | --26.78K | ---- |
| Unrealized gains and losses of investment securities | --0 | 140.02%49.71K | 56.70%-7.65K | -374.03%-206.88K | -252.27%-80.29K | 49.78%15.29K | -178.93%-124.22K | 87.81%-17.66K | -22.96%75.49K | 26.75%52.73K |
| Other non cashItems | 10,233.75%8.27K | 2,537.66%2.03K | 2,932.91%2.4K | 966.24%3.35K | 3,839.24%3.11K | 0.00%80 | 1.32%77 | 0.00%79 | 100.21%314 | 100.05%79 |
| Change In working capital | 200.19%30.38K | 96.81%-12.61K | 9.15%15.52K | -263.67%-353.51K | -54.11%57.51K | 16.10%-30.32K | -991.07%-394.91K | -82.77%14.22K | 290.83%215.99K | 56,090.58%125.31K |
| -Change in receivables | 93.84%-927 | -135.11%-3.79K | 1,192.78%7.87K | -104.77%-2.22K | 274.78%13.83K | -322.04%-15.05K | -28.45%-1.61K | -98.72%609 | 193.12%46.59K | 107.97%3.69K |
| -Change in prepaid assets | 31.12%-8.83K | 468.13%14.83K | -438.60%-15K | --0 | --13K | -10,199.21%-12.83K | -84.54%2.61K | 78.66%-2.79K | 866.73%3.96K | --0 |
| -Change in payables and accrued expense | 1,741.05%40.14K | 94.03%-23.65K | 38.13%22.65K | -333.51%-351.29K | -71.23%30.68K | 92.52%-2.45K | -1,480.11%-395.91K | -65.73%16.4K | 340.19%150.44K | 482.02%106.61K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --15K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 95.39%-17.38K | 91.23%-42.26K | 64.20%-11.21K | -1,775.18%-896.99K | -117.52%-6.56K | -270.11%-377.03K | -2,831.35%-482.09K | -194.69%-31.32K | 84.65%-47.84K | 27.87%37.41K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 23.37%92.63K | 82 | -109.97%-75K | 0 | 109.98%75.08K | 0 | 752.22K | ||
| Net investment purchase and sale | --0 | 23.37%92.63K | ---- | --75.08K | --0 | --0 | 109.98%75.08K | ---- | --0 | --752.22K |
| Net other investing changes | ---- | ---- | ---- | ---75K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | 23.37%92.63K | ---- | --82 | -109.97%-75K | --0 | 109.98%75.08K | ---- | --0 | --752.22K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Cash from discontinued financing activities | ||||||||||
| Net cash flow | ||||||||||
| Beginning cash position | -53.72%361.4K | -73.82%311.03K | -73.57%322.25K | -3.78%1.22M | -5.99%403.8K | 47.04%780.83K | -8.63%1.19M | -3.78%1.22M | -20.24%1.27M | -65.30%429.53K |
| Current changes in cash | 95.39%-17.38K | 112.38%50.37K | 64.20%-11.21K | -1,775.01%-896.91K | -110.33%-81.56K | -271.42%-377.03K | 47.07%-407.01K | -194.69%-31.32K | 85.12%-47.84K | 2,599.38%789.62K |
| End cash Position | -14.80%344.03K | -53.72%361.4K | -73.82%311.03K | -73.57%322.25K | -73.57%322.25K | -5.99%403.8K | 47.04%780.83K | -8.63%1.19M | -3.78%1.22M | -3.78%1.22M |
| Free cash from | 95.39%-17.38K | 91.23%-42.26K | 64.20%-11.21K | -1,775.18%-896.99K | -117.52%-6.56K | -270.11%-377.03K | -2,831.35%-482.09K | -194.69%-31.32K | 84.65%-47.84K | 27.87%37.41K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.